Fengting Liu

2.2k total citations
74 papers, 1.7k citations indexed

About

Fengting Liu is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Fengting Liu has authored 74 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Fengting Liu's work include Cell death mechanisms and regulation (13 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Fengting Liu is often cited by papers focused on Cell death mechanisms and regulation (13 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Fengting Liu collaborates with scholars based in China, United Kingdom and United States. Fengting Liu's co-authors include Li Jia, Adrian C. Newland, Samir Agrawal, John G. Gribben, Bao‐Xiang Zhao, Stephen M. Kelsey, Hongyin Gao, Timothy Farren, Lirong Guo and Lei Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Fengting Liu

71 papers receiving 1.7k citations

Peers

Fengting Liu
Emmanuelle J. Meuillet United States
Xiaoqing Shi China
Frank Bennett United States
Paul P. Tamburini United States
Daniel H. Albert United States
Michael Huang Australia
Mamoru Shoji United States
Angelica M. Merlot Australia
Satyanarayana Ande United States
Emmanuelle J. Meuillet United States
Fengting Liu
Citations per year, relative to Fengting Liu Fengting Liu (= 1×) peers Emmanuelle J. Meuillet

Countries citing papers authored by Fengting Liu

Since Specialization
Citations

This map shows the geographic impact of Fengting Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengting Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengting Liu more than expected).

Fields of papers citing papers by Fengting Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengting Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengting Liu. The network helps show where Fengting Liu may publish in the future.

Co-authorship network of co-authors of Fengting Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengting Liu. A scholar is included among the top collaborators of Fengting Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengting Liu. Fengting Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Bo, Fengting Liu, Lingyun Dai, et al.. (2025). The nuclear phosphoinositide-p53 signalosome in the regulation of cell motility. Protein & Cell. 16(10). 840–857. 4 indexed citations
2.
Liu, Fengting, Shuo Wang, Pengfei Jiang, et al.. (2024). A near-infrared fluorescent probe based FRET for ratiometric sensing of H2O2 and viscosity in live cells. Talanta. 275. 126135–126135. 13 indexed citations
3.
4.
Liu, Fengting, Hao Sun, Xin Liang, et al.. (2023). SUMO1 Modification Stabilizes TET3 Protein and Increases Colorectal Cancer Radiation Therapy Sensitivity. International Journal of Radiation Oncology*Biology*Physics. 117(4). 942–954. 4 indexed citations
5.
Chen, Yongshun, Fengting Liu, Hui‐Ying Yu, et al.. (2023). A novel fluorescent probe for ultra-fast detection of CORM-3 and spatiotemporal multi-organelle targeting. Sensors and Actuators B Chemical. 399. 134824–134824. 4 indexed citations
6.
Liu, Fengting, et al.. (2023). A ratiometric fluorescent probe based on the FRET platform for the detection of sulfur dioxide derivatives and viscosity. Analytica Chimica Acta. 1288. 342184–342184. 13 indexed citations
7.
8.
Chen, Xinrui, Huaqing Wang, Xiuhua Sun, et al.. (2021). Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study. Annals of Translational Medicine. 9(24). 1769–1769. 7 indexed citations
9.
Zheng, Hong, et al.. (2020). Comprehensive Analysis of lncRNA‐Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms’ Tumor. BioMed Research International. 2020(1). 4951692–4951692. 20 indexed citations
10.
Zhang, Ping, Wenjing Zheng, Fengting Liu, Yu Yao, & Xinli Wang. (2020). Effect of modified early warning score combined with clinical nursing pathway on emergency rescue effect of acute myocardial infarction patients. Minerva Medica. 1 indexed citations
11.
Liu, Fengting, et al.. (2020). Involvement of NF-κB in the reversal of CYP3A down-regulation induced by sea buckthorn in BCG-induced rats. PLoS ONE. 15(9). e0238810–e0238810. 6 indexed citations
12.
Wang, Huaqing, et al.. (2019). Increased autocrine interleukin‐6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia. Journal of Cellular Physiology. 234(8). 13994–14006. 21 indexed citations
13.
Kang, Xiaolin, et al.. (2019). NF-κB-mediated regulation of rat CYP2E1 by two independent signaling pathways. PLoS ONE. 14(12). e0225531–e0225531. 21 indexed citations
14.
Wang, Peiguo, et al.. (2018). Lower expression of Bax predicts poor clinical outcome in patients with glioma after curative resection and radiotherapy/chemotherapy. Journal of Neuro-Oncology. 141(1). 71–81. 19 indexed citations
15.
Liu, Fengting, Li Jia, Ping Wang, et al.. (2015). CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 22(10). 2462–2469. 15 indexed citations
16.
Liu, Fengting, Samir Agrawal, Zanyar Movasaghi, et al.. (2008). Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood. 112(9). 3835–3846. 72 indexed citations
17.
Hao, Jihui, Ming Yu, Jia Li, et al.. (2007). Synergistic effects of proteasome inhibitor on TRAIL-induced apoptosis in malignant lymphoma cells. Clinical Oncology and Cancer Research. 34(3). 129–131. 1 indexed citations
18.
Liu, Fengting, Lindsey K. Goff, Jianhua Hao, Adrian C. Newland, & Li Jia. (2004). Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line. APOPTOSIS. 9(3). 377–384. 29 indexed citations
19.
Liu, Fengting, Stephen M. Kelsey, Adrian C. Newland, & Li Jia. (2002). Liposomal encapsulation diminishes daunorubicin‐induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells. British Journal of Haematology. 117(2). 333–342. 26 indexed citations
20.
Liu, Fengting, Stephen M. Kelsey, Adrian C. Newland, & Li Jia. (2001). Generation of reactive oxygen species is not involved in idarubicin‐induced apoptosis in human leukaemic cells. British Journal of Haematology. 115(4). 817–825. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuelle J. Meuillet Breakdown of academic impact, for papers by Xiaoqing Shi Breakdown of academic impact, for papers by Frank Bennett Breakdown of academic impact, for papers by Paul P. Tamburini Breakdown of academic impact, for papers by Daniel H. Albert Breakdown of academic impact, for papers by Michael Huang Breakdown of academic impact, for papers by Mamoru Shoji Breakdown of academic impact, for papers by Angelica M. Merlot Breakdown of academic impact, for papers by Satyanarayana Ande
Rankless by CCL
2026